About Us
Company Profile
Leadership care
memorabilia
development strategy
Management Team
party-mass work
Enterprise honor
Industry
Cement
Pharmaceutical
Health
Supply chain
Cable
Investor Relations
Main body overview
Business Summary
Governance structure
Temporary Announcement
Periodic announcements
Dividend payout
Contact Information
talent resources
talent concept
Recruitment Position
Staff training
Working environment
News
Peak Report
News reports
Contact Us
undefined
2020-08-05
Jianfeng Group Lin2016 -002 (Announcement on Withdrawal of Two Drug Registration Applications by Subsidiates)
View Details
Jianfeng Group Pro 2015-028 (Announcement of Resolutions of the 5th Session of the 9th Board of Directors)
Jianfeng Group Lin2015 -027 (GMP for Chinese Herbal Medicine)
Jianfeng Group Lin2015 -032 (GMP for Chinese Herbal Medicine)
Jianfeng Group Pro 2015-026 (API GMP)
Jianfeng Group Pro 2016-024 (Corporate Bond Tracking Rating)
Peak Group Lin2016 -023 (Announcement on the Implementation Results of "13 Peak 01" Corporate Bond Resale)
2020-07-31
Cefmenoxime Hydrochloride for Injection Instructions
Jianfeng Group's First Quarter Report 2016_Text
Summary of Jianfeng Group's 2015 Annual Report